Membrane charge dependent states of the β-amyloid fragment Aβ (16-35) with differently charged micelle aggregates

Biochimica et Biophysica Acta - Biomembranes

Volumn 1798, Issue 3, 2010, Pages 660-671

  Grimaldi, Manuela ^a   Scrima, Mario ^a   Esposito, Cinzia ^a   Vitiello, Giuseppe ^b   Ramunno, Anna ^a   Limongelli, Vittorio ^b   D'Errico, Gerardino ^b   Novellino, Ettore ^b   D'Ursi, Anna Maria ^a  

^a UNIVERSITY OF SALERNO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Amyloid peptide; EPR spectroscopy; Micelle solution; NMR spectroscopy; Spin labeled peptide

Indexed keywords

AMPHOLYTE; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN(16-35); METHYL 3 (2,2,5,5 TETRAMETHYL 1 OXYPYRROLINYL)METHANETHIOLSULFONATE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; DERIVATIZATION; ELECTRON SPIN RESONANCE; MICELLE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; PROTON NUCLEAR MAGNETIC RESONANCE; SOLID PHASE SYNTHESIS; SPIN LABELING; SURFACE CHARGE;

AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; CELL MEMBRANE; CIRCULAR DICHROISM; COMPUTER SIMULATION; ELECTRON SPIN RESONANCE SPECTROSCOPY; INDICATORS AND REAGENTS; MAGNETIC RESONANCE SPECTROSCOPY; MICELLES; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION; PROTEIN STRUCTURE, QUATERNARY; SPIN LABELS; STATIC ELECTRICITY;

EID: 76749118593     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2009.12.012     Document Type: Article

References (95)

1. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81 (2001) 741-766
2. Walsh D.M., and Selkoe D.J. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44 (2004) 181-193
3. Sipe J.D., and Cohen A.S. Review: history of the amyloid fibril. J. Struct. Biol. 130 (2000) 88-98
4. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
5. Haataja L., Gurlo T., Huang C.J., and Butler P.C. Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis. Endocr. Rev. 29 (2008) 303-316
6. Temussi P.A., Masino L., and Pastore A. From Alzheimer to Huntington: why is a structural understanding so difficult?. EMBO J. 22 (2003) 355-361
7. Selkoe D.J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399 (1999) A23-A31
8. Iversen L.L., Mortishire-Smith R.J., Pollack S.J., and Shearman M.S. The toxicity in vitro of beta-amyloid protein. Biochem J. 311 Pt 1 (1995) 1-16
9. Kirschner D.A., Abraham C., and Selkoe D.J. X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation. Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 503-507
10. Soto C., Castano E.M., Frangione B., and Inestrosa N.C. The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation. J. Biol. Chem. 270 (1995) 3063-3067
11. McLaurin J., Yang D., Yip C.M., and Fraser P.E. Review: modulating factors in amyloid-beta fibril formation. J. Struct. Biol. 130 (2000) 259-270
12. Sciarretta K.L., Gordon D.J., and Meredith S.C. Peptide-based inhibitors of amyloid assembly. Methods Enzymol. 413 (2006) 273-312
13. Soto C., Sigurdsson E.M., Morelli L., Kumar R.A., Castano E.M., and Frangione B. Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nat. Med. 4 (1998) 822-826
14. Tjernberg L.O., Naslund J., Lindqvist F., Johansson J., Karlstrom A.R., Thyberg J., Terenius L., and Nordstedt C. Arrest of beta-amyloid fibril formation by a pentapeptide ligand. J. Biol. Chem. 271 (1996) 8545-8548
15. Luhrs T., Ritter C., Adrian M., Riek-Loher D., Bohrmann B., Dobeli H., Schubert D., and Riek R. 3D structure of Alzheimer's amyloid-beta(1-42) fibrils. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 17342-17347
16. Hoyer W., Grönwall C., Jonsson A., Ståhl S., and Härd T. Stabilization of a -hairpin in monomeric Alzheimer's amyloid- peptide inhibits amyloid formation. Proc. Natl. Acad. Sci. 105 (2008) 5099
17. Gorbenko G.P., and Kinnunen P.K. The role of lipid-protein interactions in amyloid-type protein fibril formation. Chem. Phys. Lipids 141 (2006) 72-82
18. Alexandrescu A.T. Amyloid accomplices and enforcers. Protein Sci. 14 (2005) 1-12
19. Harper J.D., and Lansbury Jr. P.T. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66 (1997) 385-407
20. Hortschansky P., Schroeckh V., Christopeit T., Zandomeneghi G., and Fandrich M. The aggregation kinetics of Alzheimer's beta-amyloid peptide is controlled by stochastic nucleation. Protein Sci. 14 (2005) 1753-1759
21. Nanga R., Brender J., Xu J., Hartman K., Subramanian V., and Ramamoorthy A. Three-dimensional structure and orientation of rat islet amyloid polypeptide protein in a membrane environment by solution NMR spectroscopy. J. Am. Chem. Soc. 131 (2009) 8252-8261
22. Haass C., and Selkoe D.J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell. Biol. 8 (2007) 101-112
23. Brender J., Lee E., Cavitt M., Gafni A., Steel D., and Ramamoorthy A. Amyloid fiber formation and membrane disruption are separate processes localized in two distinct regions of IAPP, the type-2-diabetes-related peptide. J. Am. Chem. Soc. 130 (2008) 6424-6429
24. Nanga R., Brender J., Xu J., Veglia G., and Ramamoorthy A. Structures of rat and human islet amyloid polypeptide IAPP1-19 in micelles by NMR spectroscopy†. Biochemistry 47 (2008) 12689-12697
25. Brender J., Hartman K., Reid K., Kennedy R., and Ramamoorthy A. A single mutation in the nonamyloidogenic region of islet amyloid polypeptide greatly reduces toxicity†. Biochemistry 47 (2008) 12680-12688
26. LaFerla F.M. Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat. Rev. Neurosci. 3 (2002) 862-872
27. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 430 (2004) 631-639
28. Selkoe D.J. Developing preventive therapies for chronic diseases: lessons learned from Alzheimer's disease. Nutr. Rev. 65 (2007) S239-S243
29. Smith P., Brender J., and Ramamoorthy A. Induction of negative curvature as a mechanism of cell toxicity by amyloidogenic peptides: the case of islet amyloid polypeptide. J. Am. Chem. Soc. 131 (2009) 4470-4478
30. Ferreira S.T., Vieira M.N., and De Felice F.G. Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases. IUBMB Life 59 (2007) 332-345
31. Soong R., Brender J., Macdonald P., and Ramamoorthy A. Association of highly compact type II diabetes related islet amyloid polypeptide intermediate species at physiological temperature revealed by diffusion NMR spectroscopy. J. Am. Chem. Soc. 131 (2009) 7079-7085
32. McLaurin J., and Chakrabartty A. Characterization of the interactions of Alzheimer beta-amyloid peptides with phospholipid membranes. Eur. J. Biochem. 245 (1997) 355-363
33. Lindström F., Bokvist M., Sparrman T., and Gröbner G. Association of amyloid- peptide with membrane surfaces monitored by solid state NMR. Phys. Chem. Chem. Phys. 4 (2002) 5524-5530
34. Bokvist M., Lindstrom F., Watts A., and Grobner G. Two types of Alzheimer's beta-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation. J. Mol. Biol. 335 (2004) 1039-1049
35. Brender J., Dürr U., Heyl D., Budarapu M., and Ramamoorthy A. Membrane fragmentation by an amyloidogenic fragment of human islet amyloid polypeptide detected by solid-state NMR spectroscopy of membrane nanotubes. BBA-Biomembranes 1768 (2007) 2026-2029
36. Kremer J.J., Pallitto M.M., Sklansky D.J., and Murphy R.M. Correlation of beta-amyloid aggregate size and hydrophobicity with decreased bilayer fluidity of model membranes. Biochemistry 39 (2000) 10309-10318
37. Ege C., Majewski J., Wu G., Kjaer K., and Lee K.Y. Templating effect of lipid membranes on Alzheimer's amyloid beta peptide. Chemphyschem 6 (2005) 226-229
38. Maltseva E., Kerth A., Blume A., Mohwald H., and Brezesinski G. Adsorption of amyloid beta (1-40) peptide at phospholipid monolayers. Chembiochem 6 (2005) 1817-1824
39. Ege C., and Lee K.Y. Insertion of Alzheimer's A beta 40 peptide into lipid monolayers. Biophys. J. 87 (2004) 1732-1740
40. Naito A., and Kawamura I. Solid-state NMR as a method to reveal structure and membrane-interaction of amyloidogenic proteins and peptides. BBA-Biomembranes 1768 (2007) 1900-1912
41. Coles M., Bicknell W., Watson A., Fairlie D., and Craik D. Solution structure of amyloid beta-peptide (1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is. Biochemistry 37 (1998) 11064-11077
42. Shao H., Jao S., Ma K., and Zagorski M.G. Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease. J. Mol. Biol. 285 (1999) 755-773
43. Jarvet J., Danielsson J., Damberg P., Oleszczuk M., and Graslund A. Positioning of the Alzheimer Abeta(1-40) peptide in SDS micelles using NMR and paramagnetic probes. J. Biomol. NMR 39 (2007) 63-72
44. Talafous J., Marcinowski K.J., Klopman G., and Zagorski M.G. Solution structure of residues 1-28 of the amyloid beta-peptide. Biochemistry 33 (1994) 7788-7796
45. Kohno T., Kobayashi K., Maeda T., Sato K., and Takashima A. Three-dimensional structures of the amyloid beta peptide (25-35) in membrane-mimicking environment. Biochemistry 35 (1996) 16094-16104
46. Fletcher T.G., and Keire D.A. The interaction of beta-amyloid protein fragment (12-28) with lipid environments. Protein Sci. 6 (1997) 666-675
47. C. Mateo, J. Gómez, J. Villalaín, J. Gonzaléz-Ros, Protein-lipid interactions: new approaches and emerging concepts, Springer, 2006.
48. Henry G., and Sykes B. Methods to study membrane protein structure in solution. Methods Enzymol. 239 (1994) 515
49. Privé G. Detergents for the stabilization and crystallization of membrane proteins. Methods 41 (2007) 388-397
50. Porcelli F., Buck-Koehntop B.A., Thennarasu S., Ramamoorthy A., and Veglia G. Structures of the dimeric and monomeric variants of magainin antimicrobial peptides (MSI-78 and MSI-594) in micelles and bilayers, determined by NMR spectroscopy. Biochemistry 45 (2006) 5793-5799
51. Porcelli F., Verardi R., Shi L., Henzler-Wildman K.A., Ramamoorthy A., and Veglia G. NMR structure of the cathelicidin-derived human antimicrobial peptide LL-37 in dodecylphosphocholine micelles. Biochemistry 47 (2008) 5565-5572
52. Rath A., Glibowicka M., Nadeau V., Chen G., and Deber C. Detergent binding explains anomalous SDS-PAGE migration of membrane proteins. Proc. Natl. Acad. Sci. 106 (2009) 1760
53. Somasundaran P., and Staff S. Encyclopedia of surface and colloid science (2006), CRC Press
54. Gorman P., Kim S., Guo M., Melnyk R., McLaurin J., Fraser P., Bowie J., and Chakrabartty A. Dimerization of the transmembrane domain of amyloid precursor proteins and familial Alzheimer's disease mutants. BMC Neurosci. 9 (2008) 17
55. Chill J.H., Louis J.M., Miller C., and Bax A. NMR study of the tetrameric KcsA potassium channel in detergent micelles. Protein Sci. 15 (2006) 684-698
56. Williamson M.P., Suzuki Y., Bourne N.T., and Asakura T. Binding of amyloid beta-peptide to ganglioside micelles is dependent on histidine-13. Biochem J. 397 (2006) 483-490
57. Mandal P., and Pettegrew J. Alzheimer's disease: NMR studies of asialo (GM1) and trisialo (GT1b) ganglioside interactions with A (1-40) peptide in a membrane mimic environment. Neurochem. Res. 29 (2004) 447-453
58. Rodziewicz-Motowidlo S., Juszczyk P., Kolodziejczyk A.S., Sikorska E., Skwierawska A., Oleszczuk M., and Grzonka Z. Conformational solution studies of the SDS micelle-bound 11-28 fragment of two Alzheimer's beta-amyloid variants (E22K and A21G) using CD, NMR, and MD techniques. Biopolymers 87 (2007) 23-39
59. Zerbe O., Mannhold R., Kubinyi H., and Folkers G. BioNMR in drug research (2003), Vch Verlagsgesellschaft Mbh
60. Berliner L., and Reuben J. Spin labeling: theory and applications (1976)
61. Powell J., II E., and Gannett P. Improvement of a critical intermediate step in the synthesis of a nitroxide-based spin-labeled deoxythymidine analog. Molecules 5 (2000) 1244-1250
62. Hankovszky H., Hideg K., and Lex L. Nitroxyls; VII. Synthesis and reactions of highly reactive 1-oxyl-2, 2, 5, 5-tetramethyl-2, 5-dihydropyrrole-3-ylmethyl sulfonates. Synthesis (1980) 914-916
63. Mustafi D., Sosa-Peinado A., Gupta V., Gordon D., and Makinen M. Structure of spin-labeled methylmethanethiolsulfonate in solution and bound to TEM-1 [beta]-lactamase determined by electron nuclear double resonance spectroscopy†. Biochemistry 41 (2002) 797-808
64. Shafer A., Kalai T., Liu S., Hideg K., and Voss J. Site-specific insertion of spin-labeled l-amino acids in xenopus oocytes†. Biochemistry 43 (2004) 8470-8482
65. Chan W., and White P. Fmoc Solid Phase Peptide Synthesis: A Practical Approach (2000), Oxford University Press, New York
66. Karim C.B., Zhang Z., and Thomas D.D. Synthesis of TOAC spin-labeled proteins and reconstitution in lipid membranes. Nat. Protoc. 2 (2007) 42-49
67. Jao S., Ma K., Talafous J., Orlando R., and Zagorski M. Trifluoroacetic acid pretreatment reproducibly disaggregates the amyloid ß-peptide. Amyloid 4 (1997) 240-252
68. Pellegrini M., and Mierke D.F. Structural characterization of peptide hormone/receptor interactions by NMR spectroscopy. Biopolymers 51 (1999) 208-220
69. Weller K., Lauber S., Lerch M., Renaud A., Merkle H.P., and Zerbe O. Biophysical and biological studies of end-group-modified derivatives of Pep-1. Biochemistry 44 (2005) 15799-15811
70. Whitmore L., and Wallace B. DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data. Nucleic Acids Res. 32 (2004) W668
71. Wesson L., and Eisenberg D. Atomic solvation parameters applied to molecular dynamics of proteins in solution. Protein Sci. 1 (1992)
72. Piantini U., Sorensen O., and Ernst R. Multiple quantum filters for elucidating NMR coupling networks. J. Am. Chem. Soc. 104 (1982) 6800-6801
73. Bax A., and Davis D. MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Res. 65 (1985) 355-360
74. Jeener J., Meier B., Bachmann P., and Ernst R. Investigation of exchange processes by two-dimensional NMR spectroscopy. J. Chem. Phys. 71 (1979) 4546
75. Goddard T., and Kneller D. SPARKY 3 software (2006), University of California, San Francisco, USA
76. Guntert P., Mumenthaler C., and Wuthrich K. Torsion angle dynamics for NMR structure calculation with the new program DYANA. J. Mol. Biol. 273 (1997) 283-298
77. Pearlman D., Case D., Caldwell J., Ross W., Cheatham III T., DeBolt S., Ferguson D., Seibel G., and Kollman P. Amber, a computer program for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to elucidate the structures and energies of molecules. Comp. Phys. Commun. 91 (1995) 1-41
78. Case D., Pearlman D., Caldwell J., Cheatham III T., Ross W., Simmerling C., Darden T., Merz K., Stanton R., and Cheng A. AMBER 5.0 (1997), University of California, San Francisco
79. Wüthrich K. NMR of Proteins and Nucleic Acids (1986), Wiley-Interscience
80. Wishart D.S., Sykes B.D., and Richards F.M. The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. Biochemistry 31 (1992) 1647-1651
81. Laskowski R.A., Rullmannn J.A., MacArthur M.W., Kaptein R., and Thornton J.M. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 8 (1996) 477-486
82. Jarvet J., Zdunek J., Damberg P., and Graslund A. Three-dimensional structure and position of porcine motilin in sodium dodecyl sulfate micelles determined by 1H NMR†. Biochemistry 36 (1997) 8153-8163
83. Lindberg M., Jarvet J., Langel U., and Graslund A. Secondary structure and position of the cell-penetrating peptide transportan in SDS micelles as determined by NMR. Biochemistry 40 (2001) 3141-3149
84. Tedeschi A., Franco L., Ruzzi M., Paduano L., Corvaja C., and D'Errico G. Micellar aggregation of alkyltrimethylammonium bromide surfactants studied by electron paramagnetic resonance of an anionic nitroxide. Phys. Chem. Chem. Phys. 5 (2003) 4204-4209
85. Esposito C., Tedeschi A., Scrima M., D'Errico G., Ottaviani M.F., Rovero P., and D'Ursi M. A, Exploring interaction of beta-amyloid segment (25-35) with membrane models through paramagnetic probes. J. Pept. Sci. 12 (2006) 766-774
86. Kivelson D. Theory of ESR linewidths of free radicals. J. Chem. Phys. 33 (1960) 1094
87. Tedeschi A., D'Errico G., Busi E., Basosi R., and Barone V. Micellar aggregation of sulfonate surfactants studied by electron paramagnetic resonance of a cationic nitroxide: an experimental and computational approach. Phys. Chem. Chem. Phys. 4 (2002) 2180-2188
88. D'Errico G., D'Ursi A., and Marsh D. Interaction of a peptide derived from glycoprotein gp36 of feline immunodeficiency virus and its lipoylated analogue with phospholipid membranes. Biochemistry 47 (2008) 5317
89. Ma B., and Nussinov R. Molecular dynamics simulations of alanine rich -sheet oligomers: insight into amyloid formation. Protein Science: A Publication of the Protein Society vol. 11 (2002) 2335
90. Crescenzi O., Tomaselli S., Guerrini R., Salvadori S., D'Ursi A., Temussi P., and Picone D. Solution structure of the Alzheimer amyloid [beta]-peptide (1-42) in an apolar microenvironment: similarity with a virus fusion domain. Eur. J. Biochem. 269 (2002) 5642
91. Sticht H., Bayer P., Willbold D., Dames S., Hilbich C., Beyreuther K., Frank R.W., and Rosch P. Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease. Eur. J. Biochem. 233 (1995) 293-298
92. Petkova A.T., Yau W.M., and Tycko R. Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. Biochemistry 45 (2006) 498-512
93. Ferguson N., Becker J., Tidow H., Tremmel S., Sharpe T.D., Krause G., Flinders J., Petrovich M., Berriman J., Oschkinat H., and Fersht A.R. General structural motifs of amyloid protofilaments. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 16248-16253
94. Iwata K., Fujiwara T., Matsuki Y., Akutsu H., Takahashi S., Naiki H., and Goto Y. 3D structure of amyloid protofilaments of beta2-microglobulin fragment probed by solid-state NMR. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 18119-18124
95. Zheng J., Ma B., and Nussinov R. Consensus features in amyloid fibrils: sheet-sheet recognition via a (polar or nonpolar) zipper structure. Phys. Biol. 3 (2006) P1-P4